Skip to content
Research Article Open access CC BY 4.0

Management of Advanced Stages of Chronic Kidney Disease Patients with the Administration of Renadyl Capsule: A Single Center Pilot Study in Bangladesh

Tanjina Rahman, Sampurna Guhathakurta, Akibul Islam Chowdhury, Fahmida Karim Munni, Harun Ur- Rashid, Shakib Arefin, M. Akhtaruzzaman, Mohammad Asadul Habib

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–10 · Published 22 Dec 2020

10.9734/jamps/2020/v22i1030195

Abstract

Background: Chronic kidney diseases become a public health concern as the rate of this diseases is increasing. Thus, the aim of the study was to evaluate the changes in key biomarkers in Bangladeshi CKD stages IV and V patients by using Renadyl capsule. Study Design: Open label randomized placebo controlled clinical trial. Methods: Data were collected from patients with CKD stage IV and V in 2017, in an out-patient setting in Kidney Foundation Hospital and Research Institute, Bangladesh. Patient’s information, medical history and clinical data were also collected. Health condition of the patients was collected by using SF-36 QOL questionnaire. Data were analyzed using SPSS software version 23.0. Results: Administration of Renadyl capsule improved the clinical and biochemical data of the patients. Renadyl administration improved the filtration rate, kidney size, creatinine level, heart rate and liver function. Patient’s physical and mental health was also improved. Conclusion: Renadyl administration appeared to be safe among chronic kidney patients with improved kidney function. However, more clinical trials are suggested to determine the efficacy and effects of Renadyl.

Chronic kidney diseases Renadyl kidney patients Bangladesh.

References (14)

  1. 1 The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
  2. 2 Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics [DOI]
  3. 3 Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk [DOI]
  4. 4 Role of Urea in Intestinal Barrier Dysfunction and Disruption of Epithelial Tight Junction in Chronic Kidney Disease [DOI]
  5. 5 Mechanisms and therapeutic effectiveness of lactobacilli [DOI]
  6. 6 Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease [DOI]
  7. 7 Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials [DOI]
  8. 8 Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis [DOI]
  9. 9 In Vitro and In Vivo Assessment of Intraintestinal Bacteriotherapy in Chronic Kidney Disease [DOI]
  10. 10 Probiotic Amelioration of Azotemia in 5/6th Nephrectomized Sprague-Dawley Rats [DOI]
  11. 11 Is there Interaction Between Gut Microbial Profile and Cardiovascular Risk in Chronic Kidney Disease Patients? [DOI]
  12. 12 Effects of probiotics on quality of life in children with cystic fibrosis; a randomized controlled trial.
  13. 13 Relationships between appetite and quality of life in hemodialysis patients [DOI]
  14. 14 The market of probiotics [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

50

Page views

0

PDF downloads

27

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.